The rising global burden of coronary artery disease and structural heart disorders is fueling demand for catheter-based interventions. Percutaneous coronary intervention (PCI), angioplasty, and atherectomy procedures rely heavily on advanced cardiology devices. Continuous innovation in biodegradable stents and imaging-guided systems is further accelerating market growth. The Minimally Invasive...